About the VP
Stephen M. Lanier (SML) received his doctorate in pharmacology from the University of Tennessee Center for Health Sciences and received postdoctoral training in the Cardiac Unit at Massachusetts General Hospital/Harvard Medical School where he was subsequently appointed as instructor and assistant professor. In 1991, he was recruited to the Department of Cell and Molecular Pharmacology and Experimental Therapeutics at the Medical University of South Carolina. SML accepted the position of chair of the Department of Pharmacology at Louisiana State University Health Sciences Center in New Orleans in March 2001. He served as the chief scientific officer, associate provost for Research and professor of Pharmacology at the Medical University of South Carolina December 1, 2006 to June 15, 2014.
On June 16th 2014, SML was appointed as professor of Pharmacology and vice president for Research at Wayne State University in Detroit, Michigan. SML has worked to establish significant partnerships with the City of Detroit and to establish programs that connect with the challenges facing the city of Detroit as we work together on one of the most special initiatives in the world. SML has launched a broad Integrative Biosciences Initiative dedicated to research, discovery, education, training and knowledge application across a range of biomedical challenges. This initiative leverages a new 200,000 sq. ft. Integrative Biosciences Center (IBio) (6135 Woodward Avenue), opened in 2015, that houses coordinated, multidisciplinary research teams and programmatic initiatives involving translational thrusts focused on pathophysiologies and accumulated stressors affecting health in evolving urban environments.
In each of his various institutional leadership roles, SML has enhanced research support operations, augmented entrepreneurial initiatives, developed new research infrastructure, nurtured growth in extramural research funding, developed strong community ties and developed significant inter-institutional collaborations and partnerships involving the public and private sector.
SML has served on multiple review panels for the National Institutes of Health and other scientific panels, provided leadership for professional organizations, established international collaborative partnerships, served as chair and organizer of multiple scientific conferences, and consulted for a number of pharmaceutical concerns and biotechnology firms. SML has served on the Board for various organizations including SCBIO, the Charleston Digital Corridor and TechTown Detroit.
SML has served on editorial boards for leading scientific journals and as director of Institutional Training Grants and two Centers of Biomedical Research Excellence. SML has trained over 40 fellows/students whom are pursuing careers in biomedical research around the world.
SML is recognized as a leading, creative investigator in the area of cell signaling and signal integration in health and disease and his work has been supported by the National Institutes of Health for almost 30 years. SML has a technical and intellectual breadth of expertise that encompasses multiple systems (cardiovascular, neuroscience, cancer, metabolism) and includes bioassays, molecular biology, biochemistry, pharmacology, structural biology and model organisms. His work has led to the development of new concepts in the field of cell signaling and has resulted in the generation of a number of new concepts in the field as well as a range of tools and resources that are widely used in the research and discovery community.